Progress toward the development of a respiratory syncytial virus vaccine
- 1 January 1995
- journal article
- vaccination
- Published by Wiley in Pediatric Pulmonology
- Vol. 19 (S11) , 81-83
- https://doi.org/10.1002/ppul.1950191141
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3–6 months after immunizationVaccine, 1993
- Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia—RSV recombinants or RSVVaccine, 1992
- Protection of BALE/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G glycoproteinVirology, 1991
- Vaccination of Cotton Rats with a Chimeric FG Glycoprotein of Human Respiratory Syncytial Virus Induces Minimal Pulmonary Pathology on ChallengeThe Journal of Infectious Diseases, 1991
- Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3–6 months after immunizationVaccine, 1990